Background: Domperidone is used to treat gastrointestinal symptoms in patients with Parkinson's disease. Because of an increased risk of cardiac adverse events, the European Medicines Agency has issued recommendations restricting its use mainly in terms of age, dose, and treatment duration.
Objective: The aim of this study was to investigate current prescription practices of domperidone in Parkinson's disease among French neurologists.